Development of targeted radionuclide therapy using tumor specific antibody for triple negative breast cancer

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201600013C
Awardee
Awarding agency
Obligated
$300,000

Award facts

Opportunity
  • PHS20161 Solicitation number
Contract value 100% obligated
$300,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 12 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Charlotte, NC 28223, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 2 $0
Supplemental Agreement for work within scope 1 · Development of targeted radionuclide therapy using a tumor specific antibody for triple negative breast cancer $0
Original award $300,000

About this award

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Oncotab, Inc. for the development of a targeted radionuclide therapy using tumor-specific antibodies for triple-negative breast cancer. The contract has a ceiling value of $300,000.00 and a performance period ending on January 31, 2018. As this is an SBIR Phase I contract, it represents an early-stage research and development effort for a novel cancer treatment approach.

Quick answers

Who was awarded contract HHSN261201600013C?

HHSN261201600013C was awarded to Oncotab, Inc. by National Cancer Institute (National Institutes of Health) on September 19, 2016.

How much is contract HHSN261201600013C worth?

The government has obligated $300,000 on HHSN261201600013C.

Was contract HHSN261201600013C competed?

The extent of competition for HHSN261201600013C was full and open competition after exclusion of sources. The government received 12 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award